Table 2.
Demographic Characteristics and Use of Medications for Cardiovascular Disease Prevention by Insurance Status and HPSA Classification at Baseline in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, 2003–2007
| Insured/non-HPSA (n=16,323) | Insured/HPSA (n=2,319) | Uninsured/non-HPSA (n=1,104) | Uninsured/HPSA (n=226) | P | |
|---|---|---|---|---|---|
| Age (years) | 65±9 | 64±9 | 58±7 | 58±7 | <0.01 |
| African American (%) | 35 | 33 | 59 | 49 | <0.01 |
| Female (%) | 54 | 53 | 62 | 62 | <0.01 |
| Education (%) | |||||
| <High school | 12 | 16 | 19 | 22 | <0.01 |
| High school | 25 | 28 | 34 | 42 | |
| Some college | 27 | 23 | 29 | 27 | |
| College + | 36 | 32 | 19 | 9 | |
| Annual Income (%) | |||||
| <$25,000 | 29 | 34 | 60 | 68 | <0.01 |
| $25–50,000 | 35 | 37 | 28 | 26 | |
| >$50,00 | 37 | 29 | 11 | 5 | |
| County Percent Poverty | 15±5 | 22±7 | 17±6 | 23±7 | <0.01 |
| Medication Adherence (%) | 65 | 68 | 59 | 60 | <0.01 |
| SF-12 PCS | 46±11 | 45±11 | 46±11 | 45±11 | <0.01 |
| CESD Score | 1±2 | 1±2 | 2±3 | 3±3 | <0.01 |
| CVD Prevention Medications* (%) | |||||
| Aspirin | 92 | 92 | 90 | 88 | NS |
| Beta-Blockers | 56 | 56 | 60 | 54 | NS |
| ACE-I/ARB | 61 | 61 | 56 | 57 | NS |
| Statins | 70 | 68 | 57 | 52 | <0.01 |
| Warfarin | 24 | 24 | 11 | 4 | <0.01 |
ACE-I = angiotensin converting enzyme inhibitor, ARB = angiotensin receptor blocker, CESD = Centers for Epidemiology Study Depression, HPSA = Health Professional Shortage Area, PCS = Physical Component Score, SF-12 = Short Form-12
*
Among those with a qualifying condition as defined in Table 1.